Cardinal Health (NYSE:CAH – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from ...
Zacks.com on MSN8d
CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View RaisedCardinal Health, Inc. CAH reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.93, which beat the ...
Cardinal Health Inc (CAH) raises EPS guidance despite a 4% revenue decline, driven by robust pharmaceutical segment ...
Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...
Cardinal Health (NYSE:CAH – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH – Research Report) and Apyx ...
Cannot destructure property 'translate' of 'n' as it is null.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback